Summit Therapeutics Inc (SMMT) Stock Could Soon Reward Patient Investors

Summit Therapeutics Inc (NASDAQ: SMMT) is -0.67% lower on its value in year-to-date trading and has touched a low of $6.78 and a high of $36.91 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SMMT stock was last observed hovering at around $18.22 in the last trading session, with the day’s loss setting it -0.49%.

Currently trading at $17.73, the stock is -26.75% and -23.90% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.12 million and changing -2.69% at the moment leaves the stock -12.87% off its SMA200. SMMT registered 503.92% gain for a year compared to 6-month gain of -7.68%. The firm has a 50-day simple moving average (SMA 50) of $23.3272 and a 200-day simple moving average (SMA200) of $20.309675.

The stock witnessed a -28.15% loss in the last 1 month and extending the period to 3 months gives it a -7.34%, and is -31.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.20% over the week and 9.14% over the month.

Summit Therapeutics Inc (SMMT) has around 159 employees, a market worth around $13.08B and $0.00M in sales. Distance from 52-week low is 161.43% and -51.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-69.33%).

The EPS is expected to shrink by -30.93% this year.

Summit Therapeutics Inc (SMMT) Top Institutional Holders

294.0 institutions hold shares in Summit Therapeutics Inc (SMMT), with institutional investors hold 86.27% of the company’s shares. The shares outstanding are 741.61M, and float is at 110.45M with Short Float at 23.30%. Institutions hold 13.54% of the Float.

The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 23.22 million shares valued at $181.13 million. The investor’s holdings represent 3.2804% of the SMMT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.82 million shares valued at $68.78 million to account for 1.2457 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.9 million shares representing 1.1158% and valued at over $61.61 million, while FMR LLC holds 1.0687 of the shares totaling 7.57 million with a market value of $59.01 million.

Summit Therapeutics Inc (SMMT) Insider Activity

#####

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.